Owning It In The Biotech C-Suite
Episode description
Recorded on 04/17/23
TD Cowen analyst Yaron Werber speaks with David Epstein, CEO of Seagen, and Laura Hamill, former EVP, Global Commercial Operations at Gilead Sciences and SVP, General Manager of US Commercial Operations at Amgen, to discuss owning their role as a C-suite executive, accountability, and being a leader in biotech companies. David and Laura offer insights on the difference between being functional area leader vs being a company leader, thinking like a CEO and not just as a head of a functional area, and highlight the key traits of successful management teams, which include clarity of purpose, willingness to prioritize and make tough early decisions, being accountable, working diligently to make the right decisions, and fostering a cohesive and communicative company culture.
For Disclosures, click here bit.ly/3cPHkNW